Christopher Holterhoff Email & Phone Number
SVP, Corporate Development @ SynOx Therapeutics
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Christopher Holterhoff Location
- New York, NY, US
Christopher Holterhoff Work
- SVP, Corporate Development @ (December 2025 - Present)
- Board of Advisors @ (May 2024 - Present)
- Independent Consultant @ Self-employed (September 2024 - December 2025)
- Business Development Consultant @ (September 2025 - November 2025)
- Senior Vice President, Head of Business Development @ (September 2023 - May 2024)
- Vice President, Business and Corporate Development @ (March 2021 - April 2023)
- Executive Director, Business and Corp. Development, Head of Transactions, Deal Finance and Alliance Mgt. @ Amicus Therapeutics (October 2019 - March 2021)
- Senior Director, Business and Corporate Development, Head of Transactions and Deal Finance @ Amicus Therapeutics (January 2018 - October 2019)
- Director of Strategy and Business Development @ Amicus Therapeutics (July 2016 - January 2018)
- Associate @ (June 2014 - July 2016)
- Associate Director, Business Development @ (February 2013 - May 2014)
- Executive Director, Bio and Specialty Pharmaceuticals Equity Research @ Oppenheimer & Co. (January 2008 - February 2013)
- Vice President @ ThinkEquity Partners (October 2006 - January 2008)
- Biotechnology Equity Research Associate @ (December 2004 - September 2006)
- Investment Banking Analyst @ (July 2004 - December 2004)
Christopher Holterhoff Education
- Columbia Business School
MBA
2010-2011 - Georgetown University
M.S.
- Providence College
B.S.
Christopher Holterhoff Skills
- Biotechnology
- Business Development
- Capital Markets
- Competitive Analysis
- Corporate Development
- Due Diligence
- Emerging Markets
- Entrepreneurship
- Equities
- Equity Research
- Financial Modeling
- Investment Banking
- Investments
- Mergers & Acquisitions
- Portfolio Management
- Private Equity
- Securities
- Start-ups
- Strategic Partnerships
- Strategic Planning
- Strategy
- Valuation
- Venture Capital
- Start Ups
- Management Consulting
- New Business Development
- Business Strategy
- Mergers and Acquisitions
Christopher Holterhoff Summary
- Christopher Holterhoff, based in New York, NY, US, is currently a SVP, Corporate Development at SynOx Therapeutics. Christopher Holterhoff brings experience from previous roles at Life Science Cares New York, Self-employed, Secretome Therapeutics and Bluejay Therapeutics. Christopher Holterhoff holds a 2010 - 2011 MBA @ Columbia Business School. With a robust skill set that includes Biotechnology, Business Development, Capital Markets, Competitive Analysis, Corporate Development and more. Christopher Holterhoff has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Christopher Holterhoff?
Find contact details for 700 million professionals.
Others Named Christopher Holterhoff
Christopher Holterhoff
SVP, Corporate Development
New York, NY, US
Top SynOx Therapeutics Employees
Raymond Barlow
Chief Executive Officer
Oxford, GB
Laura Lawrence
Executive Director, Clinical Operations
United States
Frank Bracken
Senior Vice President of Quality
County Westmeath, Ireland
Dan Tanner
Finance and IT Systems Manager
England, United Kingdom
Christopher Holterhoff
SVP, Corporate Development
New York, NY, US
Christine Obercian
Director, Clinical Operations
West Chester, PA, US
Raelin
Executive Director Analytics and Insights
Boston, MA, US
Elyse Seltzer
Chief Medical Officer
Philadelphia, PA, US
Katie Rudge
Associate Director, Clinical Operations
London, England, GB
Elizabeth Cairns
Executive Assistant
Reading, GB
Joe Heikkinen
SVP, Head of Sales
Texas, United States
Ruth Coll.
Senior Clinical Study Director
Crowthorne, GB
Luke Gray
Senior Director, Finance
United Kingdom
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co